nad has been researched along with Constriction, Pathological in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Ruby, PK; Sharma, SS; Sistla, R; Yerra, VG | 1 |
| Gongadze, NV; Sukoyan, GV | 1 |
| Cai, Y; Chen, SR; Ji, Y; Liu, PQ; Pi, RB; Shen, XY; Ye, JT; Yu, SS | 1 |
3 other study(ies) available for nad and Constriction, Pathological
| Article | Year |
|---|---|
PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy.
Topics: Animals; Benzamides; Constriction, Pathologic; Cyclooxygenase 2; Hyperalgesia; Inflammation; Male; NAD; Neuritis; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peripheral Nervous System Diseases; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Sensation; Tyrosine; Walking | 2016 |
Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency.
Topics: Acetyldigoxins; Adenosine; Adenosine Triphosphate; Animals; Apoptosis; Cardiotonic Agents; Constriction, Pathologic; Female; Heart; Heart Failure; Heart Ventricles; Hydrazones; Male; Milrinone; Myocardium; Myocytes, Cardiac; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyridazines; Rabbits; Reperfusion; Simendan; Ventricular Function | 2011 |
Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Male; Myocytes, Cardiac; NAD; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Messenger; Sirtuins; Transcription, Genetic; Ultrasonography; Up-Regulation | 2013 |